Most human carcinoma cell lines lack the high-affinity receptors for adenovirus serotype 5 (Ad5) at their surface and are nonpermissive to Ad5. We therefore tested the efficiency of retargeting Ad5 to alternative cellular receptors via immunoglobulin (Ig)-binding domains inserted at the extremity of short-shafted, knobless fibers. The two recombinant Ad5's constructed, Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2, carried tandem Ig-binding domains from Staphylococcal protein A (abbreviated Z wt ) and from Streptococcal protein G (C2), respectively. Both viruses bound their specific Ig isotypes with the expected affinity. They transduced human carcinoma cells independently of the CAR pathway, via cell surface receptors targeted by specific monoclonal antibodies, that is, EGF-R on A549, HT29 and SW1116, HER-2/ neu on SK-OV-3 and SK-BR-3, CA242 (epitope recognized by the monoclonal antibody C242) antigen on HT29 and SW1116, and PSMA (prostate-specific membrane antigen) expressed on HEK-293 cells, respectively. However, Colo201 and Colo205 cells were neither transduced by targeting CA242 or EGF-R nor were LNCaP cells transduced by targeting PSMA. Our results suggested that one given surface receptor could mediate transduction of certain cells but not others, indicating that factors and steps other than cell surface expression and virus-receptor interaction are additional determinants of Ad5-mediated transduction of tumor cells. Using penton base RGD mutants, we found that one of these limiting steps was virus endocytosis. Gene Therapy (2005) 12, 211-224.
Introduction
Adenoviruses (Ad) are now widely used for gene therapy applications and have many benefits such as high yields of vector production, a high transduction efficiency, the ability to infect resting and proliferating cells and a high in vivo stability. 1 However, as with most viral vectors, Ad have a broad cellular tropism and need to be restricted to desired cell types to gain in efficiency and safety in vivo. Furthermore, Ad with wild type (WT) tropism is often inefficient in infecting human tumor cells. 2 There is therefore a need to identify surface molecules on tumor cells that could act as alternative receptors for Ad, and to develop methods to retarget Ad vectors to these receptors.
Adenovirus serotype 5 (Ad5) infection is mediated by the high-affinity binding of the fiber knob to the Coxsackie B3 virus and Ad receptor (CAR), and to the major histocompatibility complex class I alpha 2 domain or glycosaminoglycans, followed by internalization mediated by the binding of RGD motifs in the penton base (Pb) to integrins a v b 3 and a v b 5 on the cell surface. [3] [4] [5] [6] [7] Retargeting of Ad can be achieved by bispecific conjugates or genetic engineering of the fiber and other capsid proteins to express a new cell-binding ligand. In bispecific conjugates, one part binds to Ad, which preferably inhibits CAR binding, and the other part binds to a cellular surface structure. [8] [9] [10] However, when bispecific conjugates are used for cell targeting, the cell specificity will be lost during the first round of replication, making genetic engineering mostly preferred for replication-competent oncolytic viruses. On the other hand, when Ad is retargeted to new cellular receptors, there is a risk that these receptors are not competent for a productive infection. Studies on the canine adenovirus type 2 have shown that infection can be blocked at the point of virus internalization, even though the virus attaches to the cells. 11 We have previously developed retargeted Ad5 in which the knob domain and the last 15 shaft repeats of the fiber gene had been replaced by an extrinsic trimerization signal and new cell-binding motifs. 12 A novel class of ligands, termed affibodyt molecules, have been shown to be well suited to be incorporated into Ad fibers as they are capable of correct folding in the reducing environment in the cell cytosol, a prerequisite for virus formation. 13, 14 Affibodies are derived from the Z domain (here abbreviated Z wt , for Z wild type (WT)), which is a cystein-free, 58-amino-acid sequence arranged in a three-helix bundle structure, derived from domain B of Staphylococcal protein A (SpA). 15, 16 In the present study, we describe two types of Ig-binding Ad recombinants, in which one carried two Z wt motifs in tandem in place of the knob and is known as Ad5/R7-Z wt -Z wt . 13 The other one, called Ad5/R7-C2-C2, carried fibers containing the C2 domain from Streptococcal protein G. Protein G binds to a broader range of immunoglobulins (Igs) compared to protein A for example, protein G is capable of binding strongly to human IgG3 and mouse IgG1, both of which bind weakly to protein A. [17] [18] [19] By taking advantage of the affinity of Z wt and C2 for the Fc domain of Igs, and of the antigen specificity of the Fab domain, various monoclonal antibodies might be adsorbed to virions of Ad5/R7-Z wt -Z wt or Ad5/R7-C2-C2, and new cellular targets could be explored as potential Ad receptors by transduction of cells carrying the corresponding antigen molecules.
In the present study, we used this method to evaluate the efficiency of tumor-associated cellular antigens as potential Ad receptors, and the possible retargeting of Ad5 to four different cell surface molecules: (i) epidermal growth factor receptor (EGF-R), (ii) HER-2/neu, (iii) CA242 (epitope recognized by the monoclonal antibody C242), and (iv) prostate-specific membrane antigen (PSMA). The rationale for their selection was the following. Overexpression of the EGF-R has been correlated with a poor prognosis in several cancers, including non-small-cell lung, prostate, breast, and colorectal cancer. 20 Many different strategies to interfere with EGFR-mediated signaling are under development. One example is the EGF-R monoclonal antibody Cetuximab that is in clinical II/III trials, in combination with chemotherapy or radiotherapy. 21 A bispecific antibody (MDX447), that has been designed to target both EGF-R and epitopes on immune effector cells and that provokes cell lysis is also in clinical trials. 22 EGF-R was our first choice of target since it was previously shown to be able to mediate Ad gene transfer. 10, 23 HER-2/neu is another member of the EGF-R family and is overexpressed in many types of human cancer, for example, breast, ovary, and lung. 24 The herceptint antibody against HER-2/neu is currently used to treat women with HER-2/neu overexpressing breast cancer. 25, 26 Bispecific conjugate with an antibody directed against HER-2/neu fused to the ectodomain of CAR has previously been shown to increase Ad gene transfer to HER-2/neu-expressing cell lines. 27 The CA242 antigen is highly expressed on colorectal carcinoma cells and capable of self-internalization (L Lindholm, unpublished data). 28, 29 Its specific antibody, C242, is used both as a diagnostic tool for gastrointestinal cancer (CanAg CA242 EIA, CanAg Diagnostics, Gothenburg, Sweden) and as a potent immunotoxin in fusion with Pseudomonas exotoxin or ricin A-chain. 30, 31 The expression of PSMA is elevated in prostate cancer as well as neoendothelial cells in carcinomas of different origin. 32 Studies with antibodies directed toward PSMA conjugated with toxins or radionuclides have been performed in vitro 33 and in vivo, 34 respectively, with promising results.
We found that some of these surface molecules could successfully act as Ad receptors in certain cell lines, but that the same molecules could be inactive in others, suggesting that factors and steps other than surface expression of receptors and virus attachment to these receptors could influence the ability of Ad5 to transduce tumor cells. Data obtained with a v -integrin-binding mutants of Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 suggested that one of the possible limiting steps was the endocytosis of the virus.
Results
Inefficient transduction of tumor cell lines by Ad5 with WT tropism and rationale for the usage of alternative receptors
The transduction efficiency of different tumor cell lines (listed in Table 1 ) was studied using Ad5/WT-fiber, a green fluorescent protein (GFP)-expressing vector with WT capsid. With the exception of the adenocarcinoma cell line HeLa, all the human tumor cell lines tested were poorly transduced, with less than 2% GFP-positive cells at a multiplicity of infection (MOI) of 5 plaque-forming units (PFU)/cell (Table 1) . 293 cells are included as a positive control since this is the production cell line for Ad5/WT-fiber, but these cells are not tumor cells. We explored the possibility that the low permissivity to Ad5 was due to a low surface expression of the Ad5 receptors, CAR and a v -integrins, on the tumor cell lines. This was measured by incubation with antibodies against CAR or a v -integrin, followed by an FITC-conjugated anti-mouse antibody and FACS measurement (Table 1) . Receptor expression was compared to 293 cells, which were efficiently transduced by Ad5/WT-fiber. Only HeLa cells expressed a larger amount of CAR, while the expression of a v -integrins varied among the cell lines.
We then designed antibody-binding Ad5 vectors, which would be redirected to tumor cell surface markers used as alternative viral receptors, by means of intermediate antibody molecules bound to the virus through their Fc domain, and to the cellular antigen through their Fab domain.
Cell-binding specificity of recombinant fibers carrying Ig-binding Ad
In a first step, we evaluated the feasibility of this antibody-mediated retargeting of Ad5 by constructing two recombinant Ad5 fibers carrying two different Ig-binding domains called Z wt and C2, respectively. Schematic diagrams of these fiber constructs are shown in Figure 1 . Z wt and C2 were inserted in tandem into the fiber shaft, replacing the knob and the last 15 shaft repeats, to generate recombinant fibers R7-Z wt -Z wt and R7-C2-C2. These fibers were expressed as recombinant proteins in baculovirus-infected insect cells. The functionality of R7-Z wt -Z wt and R7-C2-C2 fibers, in terms of cell-binding specificity, was assayed by FACS analysis, using control 293 cells or their corresponding Fc-expressing cells, 293Fc3 (1) , in comparison with WT fiber. The WT fiber was found to bind to both cell lines (Figure 2a and b) , as expected, while R7-Z wt -Z wt and R7-C2-C2 fibers only bound to 293Fc3(1) cells (Figure 2c-f) .
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Rescue of R7-Z wt -Z wt and R7-C2-C2 fibers into Ad5 virions and their functionality
The recombinant fiber genes coding for R7-Z wt -Z wt and R7-C2-C2 were reintroduced into the Ad5-GFP genome, using a previously described method, to yield viruses Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2, respectively. 13 The recombinant virus could be purified to approximately the same number of physical particles (pp)/ml as the Ad5/WT-fiber, but the infectious titer (PFU/ml) and gene transfer efficiency (fluorescent forming units (FFU)/ml) were lower in the recombinants as has been shown earlier for Ad5/R7-Z wt -Z wt (Table 2) . 13 The number of fiber copies per virion for the recombinant Ad5/R7-Z wt -Z wt , as immunologically assayed, was previously reported to be lower than that of Ad5/WTfiber. 13 In the case of recombinant Ad5/R7-C2-C2 virus, the fiber content was found to be increased compared to Ad5/R7-Z wt -Z wt ( Figure 3) .
The cell specificity of the recombinant viruses was assayed on 293 and 293Fc3(1) cells, in comparison with the Ad5/WT-fiber virus. As shown in Figure 4 , Ad5/WTfiber-mediated gene transfer slightly more efficiently in 293 cells compared to 293Fc3(1) (40 versus 20% GFPpositive cells at an MOI of 5), most likely due to higher levels of CAR on 293 cells (Table 1) . Unexpectedly, the results were different for the two recombinant Ads. Ad5/R7-Z wt -Z wt transduced efficiently 293Fc3(1) cells (30%) but not 293 cells (1.5%) as already observed, 13 whereas Ad5/R7-C2-C2 transduced both 293Fc3(1) cells (65%) and 293 cells (34%) (Figure 4 ). When the specificity of the recombinant viruses was tested on different tumor cell lines, Ad5/R7-C2-C2 showed a relatively high background gene transfer to a few cell lines (ie HeLa, A431 and COS7 cells), while Ad5/R7-Z wt -Z wt showed very low or nonmeasurable gene transfer (data not shown).
The unspecific gene transduction of 293 cells mediated by Ad5/R7-C2-C2 could be blocked by preincubation of the virus with mouse serum (Figure 5a ), or with purified mouse IgG (Figure 5b ). Both of these treatments only slightly affected the transduction with Ad5/WT-fiber.
It has been reported that protein G (from which the C2 domain was originally issued) could bind to both Fc and Fab domains of IgG. 17 It was therefore possible that antibody molecules induced the formation of crosslinked aggregates of Ad5/R7-C2-C2 vector particles, through both Fc and Fab binding, a phenomenon which would occur at low antibody concentrations and disappear when aggregates were dissolved at higher antibody concentrations. These vector-antibody aggregates (not occurring with Ad5/R7-Z wt -Z wt ) could be responsible for the high transduction background of 293 cells by Ad5/R7-C2-C2 via nonspecific cellular adsorption and The number of pp/ml of CsCl-purified virus were determined by optical absorbance.
b PFU/ml were determined by endpoint dilution. 
After incubation with gold-tagged polyclonal IgG from goat ( Figure 6 ), a vast majority of the Ad5/R7-C2-C2 vector particles were found to be gold-labeled (86.5713.0%, n ¼ 215), and the colloidal gold grains were located at or in the close vicinity of one of the apices of the icosahedral capsid, confirming the specific binding of IgG to the C2-liganded fibers (Figure 6a and b) . In addition, a significant proportion of virions were found to be associated with more than one gold grain ( Figure 6a and c-e). This suggested that, even though Ad5/R7-C2-C2 had a lower fiber copy number compared to Ad5/ WT-fiber virions (Figure 3 ), there were probably very few, if any, fiberless particles. However, when Ad5/R7-C2-C2 virions were preincubated with monoclonal IgG2a (irrelevant to Ad), then vector-Ab complexes reacted with gold-tagged protein G, only 6% Ad5/R7-C2-C2 virions (6.271.1%, n ¼ 96) were found to be associated with gold-tagged protein G (not shown). This low binding capacity strongly suggested that most of the Fc domains of IgG2a were occupied by C2 motifs, and that only a few Fc domains of the complexes (belonging to rare IgG molecules bound to C2 motifs via their Fab domains) were left available to protein G binding. 17 Alternatively and not exclusively, gold labeling of Ad5/ R7-C2-C2 virion-antibody complexes by gold-tagged protein G might represent the minor proportion of protein G molecules binding to Fab domains. 17 Whatever the mechanism, our EM data demonstrated that, even at relatively low antibody concentrations, the majority of the Ad5/R7-C2-C2 vector particles were complexed with IgG, and that most of the C2-ligand-bound IgG had their Fab domains in the proper outward orientation, made available to the targeted cell surface antigens.
Binding of Ig subclasses and individual monoclonal antibody to recombinant Ig-binding viruses
Both the Z wt and C2 domains in their natural context possess different affinities for the different Ig subclasses. Their binding behavior in a foreign context, as virionencapsidated ligands, was studied by dot-blot assays. In these assays, recombinant viruses were immobilized onto membranes, and then the membranes were reacted with antibodies of different isotypes, and with antibodies directed against different cell surface molecules ( Figure  7 ). Ad5/R7-C2-C2 bound to mouse Ig of all four subclasses (IgG1, IgG2a, IgG2b and IgG3), while Ad5/ R7-Z wt -Z wt showed strong binding to IgG2a, IgG2b and 
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IgG3, and weak binding to IgG1 (Figure 7a ). The Ad5/ R7-C2-C2 virus bound to monoclonal antibodies against EGF-R, CA242, PSMA and HER-2/neu (Figure 7b and c) , while the Ad5/R7-Z wt -Z wt virus bound to antibodies against PSMA and HER-2/neu (Figure 7b and c) . This was consistent with their respective specific isotypes ( Figure 7 and refer to Materials and methods). The Ab directed against CD28 was not readily bound by any of the viruses (Figure 7b ). An anti-knob mouse monoclonal antibody was included to verify the presence of Ad5/ WT-fiber. This antibody was also bound by Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 via the Fc domain. Ad5/R7-C2-C2 showed some F(ab) 2 binding to the secondary antibody used in addition to the Fc binding capacity, which has also been reported before. 17 Retargeting Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 to tumor cell markers
The feasibility and efficiency of our antibody-mediated retargeting of Ad5 was then evaluated using four different cellular antigens as models: (i) EGF-R, (ii) CA242, (iii) HER-2/neu and (iv) PSMA. Table 3 summarizes the transduction experiments with the different cellular targets and cell lines.
Retargeting to EGF-R on human lung and colorectal carcinoma cells. The Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 viruses were first preincubated with increasing concentrations (0-10 mg/ml) of mouse anti-EGF-R antibody (IgG2b subclass), and the virus-antibody complex used to infect A549 cells, a human lung carcinoma cell line. Gene transfer to A549 cells mediated by Ad5/R7-C2-C2 virus increased with the antibody concentration in a dose-dependent manner, with a 10-fold enhancement between 0 and 0.5 mg/ml (Figure 8 ). Gene transduction appeared to plateau between 0.5 and 1.0 mg/ml, after which it gradually decreased for higher antibody concentrations. This inhibitory effect was most likely due to the excess of unbound antibody, acting as a Retargeting to CA242 on human colorectal carcinoma cells. The same four colorectal carcinoma cell lines, Colo201, Colo205, HT29 and SW1116, were also tested as host cells for Ad5 via CA242 targeting. As for the EGF-R targeting shown above, gene transfer to HT29 and SW1116 cells was increased nine-and six-fold, respectively, when Ad5/R7-C2-C2 virus was complexed with C242 antibody, specific for the CA242 antigen, compared to control Ad5/R7-C2-C2 (Figure 9b , SW1116 not shown). Again, no gene transfer could be detected in Colo201 and Colo205 using C242 antibody (not shown). The latter result could not be explained by the difference in the patterns of CA242 expression and cell binding of C242-bound Ad5/R7-C2-C2 virus between HT29 and Colo205 cells, since a larger fraction of the Colo205 cells than of the HT29 cells expressed the CA242 antigen and bound the virus-antibody complexes, as shown by confocal immunofluorescence analysis ( Figure 10 ).
Retargeting to HER-2/neu on human ovarian and breast carcinoma cells. Preincubation of Ad5/R7-C2-C2 or Ad5/R7-Z wt -Z wt with the herceptin antibody resulted in a significant enhancement (10-to 30-fold) in gene transfer to the human ovarian carcinoma cell line SK-OV-3 (Figure 11a and c) , as well as to the human breast carcinoma cell line SK-BR-3 (Figure 11b and d) .
Retargeting to PSMA. The 293 cells were modified to stably express membrane-bound PSMA (293PSMA). With Ad5/R7-Z wt -Z wt complexed with anti-PSMA antibody, the gene transfer to 239PSMA cells was approximately Antibody-binding Ad for targeted gene delivery P Henning et al two to six times higher compared to control 293 cells (Figure 12 ). Ad5/R7-C2-C2 was not assayed in these experiments, since this virus showed a high background transducing efficiency of control 293 cells in the absence of any monoclonal antibody (Figure 4) . No significant gene transfer to LNCaP human prostate carcinoma cells using anti-PSMA-bound Ad5/R7-Z wt -Z wt or Ad5/R7-C2-C2 was observed (data not shown). However, PSMA expression was demonstrable on LNCaP cells, although at lower levels than on 293PSMA cells (data not shown).
Stability of Ad-Ab complexes
Since Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 were prototype vectors destined to be used in vivo, in an environment containing circulating antibodies, we tested the stability of Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 complexed with the cell-targeting mouse monoclonal antibody (mAb) in the presence of excess mouse or human Ig. When Ad5/R7-C2-C2 coated with anti-EGF-R were incubated with increasing concentrations of normal mouse or human serum prior to incubation with target cells, the antibody-mediated gene transfer was completely abolished by 5% serum (data not shown). This strongly suggested that the targeting EGF-R antibodies were readily competed for and displaced from the IgGbinding domain by Ig present in the serum. The same was seen with Ad5-herceptin complexes. The antibodymediated gene transfer was completely abolished when Ad5/R7-C2-C2-herceptin and Ad5/R7-Z wt -Z wt -herceptin complexes were incubated with 50% whole normal mouse or human serum (data not shown).
Transduction of tumor cell lines by nonintegrin-binding viruses
The possible role of plasma membrane integrins in gene transfer via retargeted Ad was envisaged to explain the failure of Ad5 to infect certain cells via surface molecules and their specific antibodies. Consistent with this role, integrin a v expression was low on Colo201 and Colo205 cells, while it was expressed on HT29 cells to similar levels as 293 cells (Table 1) . However, integrin a v expression on SW1116 was similar to the expression on Colo201 and Colo205 cells, and SW1116 cells were found to be permissive to Ad5 infection via EGF-R and CA242, whereas Colo201 and Colo205 cells were not. This discrepancy suggested that the level of integrin expression at the cell surface was not the only parameter that would account for the integrin involvement in the efficiency of Ad5 retargeting. We further investigated this mechanism by using integrin-binding mutant viruses assayed in the three carcinoma cell lines A549, HT29 and SK-OV-3. The Pb capsomers of Ad5/R7-C2-C2 and Ad5/R7-Z wt -Z wt were mutated such that they carried a single amino-acid substitution changing the RGD motifs to EGD. The mutants called Ad5/R7-C2-C2/ Pb-EGD and Ad5/R7-Z wt -Z wt /Pb-EGD, respectively, were preincubated with antibodies against EGF-R (for targeting A549), CA242 (for targeting HT29) or HER-2/ neu (for targeting SK-OV-3). No detectable gene transfer was observed in any of the three cell lines using one or the other RGD-mutant virus (data not shown). This demonstrated that the interaction between RGD-dependent integrins on the cell surface, and Pb capsomers on the virion was an important requirement for internalization by tumor cells of the two Ig-binding viruses Ad5/ R7-C2-C2 and Ad5/R7-Z wt -Z wt via EGF-R, CA242 and HER-2/neu antigens.
Discussion
The need to find alternative cellular receptors for targeting of adenoviruses to tumor cells is clearly Figure 10 Cell binding of Ad and CA242 expression in colon carcinoma cell lines HT29 (a-d) and Colo205 (e-h). Ad5/R7-C2-C2 was preincubated with C242 antibody (5 mg/ml) and the virus-antibody complex added to cells at 2.5 PFU/cell, and maintained at 41C for 30 min. Ad5/R7-C2-C2 was detected with FITC-conjugated anti-hexon (a, e) and C242 antibody was detected with TRITC-conjugated anti-mouse Ig (b, f). Overlay pictures are shown in panels c, d, g, and h.
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demonstrated by the inability of Ad with WT tropism to infect most of the human tumor cell lines, as demonstrated in this study and previously by others. 2 The necessary retargeting of Ad to receptors on tumor cells that will allow for infection may be achieved by genetic engineering of Ad to express a suitable cell-binding ligand or by the use of bispecific reagents to direct the virus to a new receptor. 13, 27, [36] [37] [38] [39] [40] Another possibility is to genetically engineer the virus to express an Ig-binding domain that could bind monoclonal antibodies, which are directed against potential new virus receptors on different cell types. The construction of such viruses has been described recently: a tandem repeat of the Z domain has been successfully incorporated into knobless fibers that have been rescued into viable virus named Ad5/R7-Z wt -Z wt . 13 Furthermore, a shortened, 33-residue version of Z, called Z33, has been incorporated into the HI loop of the Ad5 fiber knob. 23 In the study by Volpers et al, the CAR-binding activity of the knob was retained, and retargeting was obtained upon preincubation of Ad5 with monoclonal antibodies against the EGF-R, neuronal cell adhesion molecule and integrin a 7 . We describe here a new Ig-binding Ad, called Ad5/R7-C2-C2, containing the C2 domain derived from Streptococcal protein G, and the application of this virus for retargeting of Ad to alternative receptors on human tumor cells, in comparison with the previously described Ad5/R7-Z wt -Z wt . In the two viruses characterized here, the CAR-binding knob domain has been genetically removed to eliminate the need for further manipulations to block the native CAR binding of the virus.
The Fc-binding activity of Ad5/R7-Z wt -Z wt and Ad5/ R7-C2-C2 was verified by binding of recombinant fibers to Fc-expressing 293 cells, and by binding of recombinant viruses to mouse monoclonal antibodies of different isotypes. Unexpectedly and in contrast to Ad5/R7-Z wt -Z wt , 13 Ad5/R7-C2-C2 showed an apparent cellular tropism different from that of its isolated fiber protein.
The viral fiber showed a specific binding to 293Fc3(1) cells and did not bind control 293 cells, whereas Ad5/R7-C2-C2 virus transduced both control and Fc-expressing 293 cells to a similar degree, and was also able to transduce a few other non-Fc-expressing cell lines. However, the transduction of control 293 cells was Antibody-binding Ad for targeted gene delivery P Henning et al completely blocked by mouse serum and purified mouse IgG. Nevertheless, these unorthodox characteristics of Ad5/R7-C2-C2 only marginally affected its use as a retargeting tool, since the Ad5/R7-C2-C2 did not infect most of the tumor cell lines tested in the absence of a targeting antibody.
Another difference between the two Ig-binding viruses was their fiber content. Ad5/R7-Z wt -Z wt was earlier shown to have a significantly decreased fiber copy number per virion, like other knobless adenoviruses. 13 By contrast, Ad5/R7-C2-C2 had a fiber content that was higher than Ad5/R7-Z wt -Z wt . This suggested that the decrease in fiber content of Ad virions caused by the absence of the fiber knob domain could be partially compensated for by the introduction into the fiber of new sequences derived from a protein domain different from the knob.
Although the Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 recombinant viruses showed binding to mouse Ig isotypes that correlated with the binding of protein A and protein G, respectively, 18 one of the monoclonal antibodies tested, anti-CD28 (mIgG1), was not bound by any of the viruses and no retargeting could be evidenced using this antibody. All the other monoclonal antibodies tested bound to one or the two viruses. This implied that every single monoclonal antibody, prior to its use for retargeting, must be tested for binding to the Ig-binding viruses to select the best-adapted pair of virus and specific antibody. A possible advantage offered by Ad5/ R7-C2-C2 is that this virus binds a broader range of Ig isotypes than Ad5/R7-Z wt -Z wt , and that it has a higher fiber content than Ad5/R7-Z wt -Z wt and could theoretically carry more antibody molecules per virion.
EGF-R and HER-2/neu have previously been shown to be able to mediate Ad gene transfer by using bispecific conjugates. 27, 38, 40, 41 The data presented here demonstrated that targeted gene delivery to cell markers EGF-R, HER-2/neu, CA242 and PSMA was also feasible using knobless, Ig-binding Ad. PSMA could be used as an alternative receptor for Ad5, at least in 293 cells expressing PSMA fused to the transmembrane domain of the platelet-derived growth factor receptor (PDGF-R). However, when antibody-mediated retargeting of Ad5 to PSMA was tested on human prostate carcinoma LNCaP cells, no gene transfer was detected, despite the fact that both PSMA and integrin a v were expressed on these cells. The absence of transduction might result from the low degree of expression of PSMA antigen at the cell surface or the difference in transmembrane domain. It could also be possible that surface antigens albeit present might not be accessible on some cell lines (eg due to complexation with other molecules) preventing the vector/antibody complexes from binding. Alternatively and not exclusively, it could also be due to a blockage in steps of the virus cycle following the initial event of receptor binding, as suggested below for Colo205 cells.
CA242 antigen and EGF-R were found to be able to mediate gene transfer in two of the human colon carcinoma cell lines tested, HT29 and SW1116, while two other cell lines, Colo205 and Colo201, both isolated from the same individual, were resistant to transduction. Both refractory cell lines express CA242 and EGF-R to significant levels, and a v -integrin was detected at similar levels in Colo201, Colo205 and SW1116 cells. Colo205 cells were also found to bind virus incubated with C242 antibody, and CA242 was certainly internalized, as evidenced by direct measurement using the isotopically labeled antibody (L Lindholm , unpublished data) and by the high toxic effect of C242 immunotoxins. 30, 31 We therefore hypothesized that the block to gene delivery in Colo205 cells would occur at the step of endocytosis of the virus, and/or the following step of virus release into the cytosol.
We also found that for all the cellular receptor antigens tested in the present investigation, including EGF-R, transduction by knobless, Ig-binding Ad was apparently dependent on the presence of the a v -integrin-binding RGD-motif in Ad Pb. This was in apparent conflict with recent results showing that mutation in the RGD motifs of Pb, destined to ablate virus-integrin interaction, actually increased the gene transfer mediated by Ad vectors retargeted by bispecific antibodies against EGF-R and epithelial cell adhesion molecule. 10 Taken together, our results and these observations strongly suggested that cellular entry and endosomal escape of Ad5 is more dependent on the integrity of integrin-binding motifs of Pb in the absence of the fiber knob domain, as in our Ad5/R7-Z wt -Z wt and Ad5/R7-C2-C2 viruses, than in knob-bearing Ad5 vectors used by van Beusechem et al.
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In this work, we used Ad5 that carried fibers lacking the knob domain and the C-terminal 15 repeats of the shaft, with WT Pb or RGD mutants. Both native Pb and fiber are known to have important functions for the endocytic pathway of WT Ad5. Following binding of the virus to the CAR receptor, the Pb binds to a v b 3 -or a v b 5 -integrins, activating the PI3K kinase cascade and triggering endocytosis into coated pits. The pH of the virus-containing endosomes drops due to acidification by proton pumps. At pH 6.0, the virus escapes to the cytosol and the microtubular transport toward the nucleus begins. There is evidence that the endosomal release of Ad5 is mediated by integrin binding of the Pb (for reviews see Meier and Greber, 42 Medina-Kauwe, 43 Chroboczek et al 44 ). However, studies on cell trafficking of chimeric Ad5 virions carrying serotype 7 fibers (Ad5Fiber7) have shown that chimeric Ad5Fiber7 particles are rerouted to the late endosomal/lysosomal lowpH compartment characteristic of Ad7. 45 This suggested that the information for the timing of endosomal escape was carried by the fibers, acting as pH sensors. 45 This hypothesis did not exclude the possibility that the fiber contains information necessary for efficient lysis of the endosome, probably in cooperation with the Pb.
The results presented in this study demonstrated that a given receptor would not necessarily mediate the gene transduction by Ad in all receptor-positive cells, and that blocks to targeted Ad gene delivery might occur in tumor cells, downstream of the primary step of virus binding to cellular receptors, as shown for the CA242 antigen on Colo205 cells. It is not known how common these block(s) are to the variety of tumor cells encountered in human pathology. They nevertheless constitute potential obstacles to the use of Ad vectors for gene therapy of human tumors, even though they only occur in a fraction of cells of a given tumor. Another recurrent obstacle is the difficulty of extrapolating in vitro models to in vivo applications. Thus, when our herceptin-or anti-EGF-R-coated viruses were incubated with mouse or human serum prior to cell infection, most of the transduction capacity was lost, indicating that the Antibody-binding Ad for targeted gene delivery P Henning et al targeting antibodies were displaced by antibodies present in the serum. It should not be concluded, however, that the system is not transposable to in vivo therapy, at least for two reasons: (i) It should be possible to stabilize these complexes by using crosslinking via bifunctional coupling reagents and (ii) the instability of Ad-antibody complexes in the presence of excess Ig represents a significant advantage when the route of vector administration in patients is the intratumoral injection. In this case, accidental (but almost inevitable) leaks of vectorantibody complex into the blood circulation would be readily neutralized by competing circulating antibodies, which would prevent gene transfer to nondesired cells and tissues. In spite of the restrictions evoked above, the Ig-binding, knobless Ad vectors described here represent simple-to-use and versatile tools that can be used as rapid alternatives to the generation of bispecific conjugates to target Ad to different receptors by using the wide variety of monoclonal antibodies available. It stands to reason that selection for targeted receptors that allow for efficient virus infection is bound to boost the efficiency of gene therapy for tumor diseases.
Materials and methods

Cells
HEK-293 cells (Ad5-transformed human embryonic kidney cells, abbreviated 293 cells) were purchased from Microbix (Toronto, Ontario, Canada) and grown in Iscove's medium (Gibco BRL, Invitrogen Life Technologies, Groningen, The Netherlands) supplemented with 10% fetal bovine serum (Sigma-Aldrich, Stockholm, Sweden) and 50 mg/ml gentamicin (Gibco BRL) and maintained at 371C and 5% CO2. The 293Fc3(1) cells were HEK-293 cells stably transfected for surface expression of Fc3(1). 13 Briefly, Fc3(1) corresponded to a human IgG3 Fc fragment engineered by replacing two amino acids with the corresponding two amino acids in Fc1 to be functionally equivalent to IgG1 Fc fragments with respect to SpA binding. 46 293PSMA cells were HEK-293 cells stably transfected for surface expression of PSMA. The gene encoding the extracellular domain of PSMA was amplified by PCR from LNCaP cDNA using primers introducing an SfiI cleavage site and an SalI cleavage site, respectively (upstream primer sequence, 5 0 -3 0 : GGGGCCCAGCCGGCCAAATCCTCCAAT GAA GCTACT; downstream primer sequence, 5 0 -3 0 : GGGG TCGACGGCTACTTCACTCAAAGTCTC). The PSMA gene was cloned into the pDisplay vector (Invitrogen, Groningen, The Netherlands). The gene fragment encoding the PSMA and PDGF-R transmembrane domain from pDisplay was subcloned into pSecTag2A (Invitrogen) and used to transfect 293 cells in passages 30-32. Foci of Zeocin-resistant cells were isolated and expanded. The 293Fc3(1) and 293PSMA cells were grown in Iscove's medium supplemented with 10% bovine serum and 100 mg/ml zeocine (Invitrogen). Human colorectal carcinoma cells (Colo205, Colo201, HT29, SW1116, SW480), human prostate carcinoma cells (LNCaP), human lung carcinoma cells (A549), human epidermoid carcinoma cells (A431), human adenocarcinoma cells (HeLa), human ovarian carcinoma cells (SK-OV-3), human rhabdomyosarcoma (RD) and human breast carcinoma cells (SK-BR-3, MDA-MB 175-VII and 415) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and grown in Iscove's medium supplemented with 10% fetal bovine serum and 50 mg/ml gentamicin (Gibco BRL) and maintained at 371C and 5% CO2. Spodoptera frugiperda Sf9 cells were from ATCC and were grown in TC100 medium (Gibco BRL) with 10% fetal bovine serum and 50 mg/ml gentamicin at 281C.
Antibodies
Mouse IgG of subclasses IgG1, IgG2a, IgG2b and IgG3 abbreviated mIgG1, mIgG2a, mIgG2b and mIgG3, respectively, were purchased from Becton Dickinson (cat. nos. 550616, 553456, 559532 and 559806, respectively, Heidelberg, Germany). Anti-HER-2/neu Herceptin (humanized mIgG1) was from Roche (Basel, Switzerland), anti-PSMA was purchased from Anogen (Y-PSMA1, mIgG2b, Yes Biotech Laboratories, Ontario, Canada) and c242 (mIgG1) was from CanAg Diagnostics AB (Gothenburg, Sweden). Anti-EGF-R (mIgG2b, cat. no. M0886), anti-CD28 (mIgG1, cat. no. M7162), horse radish peroxidase (HRP)-conjugated anti-human IgG rabbit F(ab) 2 (cat. no. P0406), HRP-conjugated goat anti-rabbit Ig (cat. no. P0448), HRP-conjugated rabbit anti-mouse Ig (cat. no. P0260) and FITC-conjugated anti-mouse IgG rabbit F(ab) 2 (cat. no. F0313) were from Dako (Glostrup, Denmark). Alkaline phosphate (AP)-conjugated antimouse IgG sheep F(ab) 2 was from Sigma-Aldrich (cat. no. A3563). Mouse monoclonal anti-knob antibody H14 was developed in-house after immunization with Ad5 virions. H14 has been shown to bind to fiber knob and to block WT Ad5 infection (data not shown). Mouse monoclonal antibody 4D2.5 (anti-Ad5 fiber tail) was kindly provided by Dr Jeffrey Engler (University of Alabama, Birmingham, AL, USA). 47 Anti-integrin a v (cat. no. CBL490) and IgG1 isotype control antibody (cat. no. CBL600) were from Chemicon (Temecula, CA, USA). Rabbit polyclonal against Pb was laboratory made. Hybridoma expressing monoclonal antibodies against human CAR was purchased from ATCC (RcmB, CRL-2379), and antibodies were produced and purified by protein A affinity chromatography. AP-conjugated antibovine IgG (cat. no. A0705) was from Sigma-Aldrich.
Generation and nomenclature of recombinant fibers
Recombinant fibers contained the N-terminal fiber tail domain and the proximal seven shaft repeats, followed, from the N-to C-terminus, by (i) an extrinsic trimerization motif from the lung surfactant protein D (neck region peptide, NRP), (ii) a linker from SpA and (iii) new cellular ligands. Schematic representations of these constructs are shown in Figure 1 . Recombinant fibers were designated R7, followed by the name of the new ligand. The construction of R7-Z wt -Z wt (Figure 1b) has been described earlier. 13 The Z wt domain was derived from the B domain of SpA. Plasmid pAC2dimer, encoding a head-to-tail dimer of the WT C2 domain of Streptococcal protein G, 48 was used as the template for PCR amplification of the C2 encoding gene fragment, using primers introducing an upstream ClaI site and a downstream stop codon followed by an XhoI site (upstream primer sequence, 5 0 -3 0 : GGGCCATCGATCA CTTACAAACTTGTTATTAAT; downstream primer sequence, 5 0 -3 0 : GGGCTCGAGTTATTCAGTAACTGTAAA GGTCTT). Recombinant Ad fiber R7-C2-C2 (Figure 1c) Antibody-binding Ad for targeted gene delivery P Henning et al was constructed by genetically replacing the Z wt -Z wt motif in R7-Z wt -Z wt with the dimeric C2 IgG-binding motif, using the ClaI and XhoI restriction sites.
Fiber expressing baculovirus and fiber binding to cells
WT and modified fibers were cloned into the pBacPak9 vector (Clontech, Palo Alto, CA, USA). Recombinant baculoviruses (Autographa californica Multiple Nuclear Polyhedrosis Virus, AcMNPV) expressing recombinant fibers were generated by homologous recombination in Sf9 cells using the BacVector-1000 DNA kit, as described by the manufacturer (Novagen, Madison, WI, USA). Sf9 cells infected with recombinant baculoviruses were lysed in hypotonic buffer (10 mM Tris-HCl buffer, pH 7.5) at 01C, the cell lysates were adjusted to isotonic conditions (150 mM NaCl in 10 mM Tris-HCl, pH 7.5) and subjected to centrifugation at 15 000 g for 10 min. Supernatants were used at working dilution of 1:5 in PBS, in fiber binding assays with 293 and 293Fc3(1) cells. The 293 and 293Fc3(1) cells were detached with nonenzymatic cell dissociation solution (Sigma-Aldrich, C5789) and washed once in PBS. After low-speed centrifugation, the cells were suspended in lysates from Sf9 cells expressing recombinant fibers and incubated for 30 min at 41C for fiber binding to occur. Cells were stained with antifiber 4D2.5 (dilution 1:1000) followed by FITC-conjugated F(ab) 2 anti-mouse IgG (dilution 1:10), with two PBS washings between every step. After the last wash, the cells were suspended in PBS and the FITC staining measured by FACS analysis (FACSsort, Becton Dickinson).
Adenoviral vectors
All viruses used were E1 deleted. The original Ad5 fiber gene was replaced by the R7-Z wt -Z wt or R7-C2-C2 fibers in the Ad5 genome as described by Magnusson et al. 12 In the resulting recombinant Ad genome, the E1 region was replaced with the GFP gene. Ad5 genome with the WT fiber cloned as the recombinant fibers and GFP in the E1 region was used to generate the control virus Ad5/WTfiber. Ad5/R7-C2-C2 and Ad5/R7-Z wt -Z wt with a Pb containing a substitution mutant in the RGD motif was constructed as follows. The Ad2 Pb-mutant R340E 49 was ligated using SmaI/AscI to a vector containing the Ad5 sequence from PmeI to SalI (map units, mu 36.9-46.6) in order to create the RGD to EGD substitution. The Ad5 fragment from SalI to NdeI (mu 46.6-54.4) was ligated to this vector, resulting in a 36.9-54.4 mu R340E Ad2/Ad5 mutant, which was joined to the rest of the Ad5 genome by cosmid cloning together with the PacI-PmeI (mu 1-36.9) and NdeI/PacI (mu 54.4-100) fragments. There is a 98.6% homology between the Pb from Ad2 and Ad5. 50 Recombinant Ad genomes were restricted with PacI and used to transfect 293 cells stably expressing cell surface anchored Fc3(1) fragment, using the FuGene technology and the manufacturer's protocol (Roche). The occurrence of plaques was determined by microscopic inspection of the transfected cell cultures. The presence of viruses was verified by PCR analysis and GFP expression. Viruses were purified from infected cells by freeze-thawing, followed by CsCl gradient centrifugation. The virus stock was titered on 293Fc3(1) cells by endpoint dilution, and the titer expressed as PFU/ml. 51 The number of pp in virus samples was determined by optical absorbance. 52 Ffu in virus samples were determined by gene transfer assay as described below. The recombinant adenoviruses were designated Ad5 followed by the name of the fiber, for example, Ad5/R7-Z wt -Z wt .
Western blot analysis of recombinant Ad5 virions
The fiber and Pb content was determined in CsClpurified Ad5 virions using SDS-PAGE and Western blot analysis. Blots were incubated with anti-tail mAb 4D2.5 diluted to 1:1000, or with rabbit polyclonal anti-Pb diluted to 1:3000 in Tris-buffered saline, pH 7.5, containing 0.05% Tween-20 (TTBS), followed by reaction with HRP-conjugated rabbit anti-mouse IgG (Dako P0260) or HRP-conjugated goat anti-rabbit IgG (Dako P0448) diluted to 1:2000 in TTBS. Membranes were washed in TTBS and developed with HRP substrate kit (Bio-Rad Laboratories, Hercules, CA, USA). The virus loads in SDS-PAGE were normalized for equal amounts of pp, determined by optical absorbance. 52 Western blots of CsCl-purified Ad5 virions (4-14 ml per lane) were reacted with anti-bovine IgG to detect any possible contaminating bovine IgG. The detection limit of the method was determined to be approximately 1 mg bovine IgG (Sigma, cat. no. L9640) per lane.
Electron microscopy
Antibody-Ad5/R7-C2-C2 complexes were observed under the EM, after reaction with different ligands. . After rinsing in Tris buffer followed by H 2 O, the specimens treated by protocols (i) and (ii) were negatively stained with 0.2% sodium phosphotungstate in H 2 O (1 min at RT), and examined under a Jeol 1200-EX EM, equipped with a MegaView II high-resolution TEM camera and a Soft Imaging System of analysis (SIS; Eloïse, Roissy, France).
Dot-blot assays for Ig-binding specificity
The specificity of binding of antibodies to Ad5/R7-ZwtZwt and Ad5/R7-C2-C2 was evaluated as follows. CsClpurified viruses were applied to PVDF membranes prewetted in ethanol and washed with Tris-buffered saline, pH 7.5 (TBS). Membranes were blocked with 3% gelatin in TBS prior to incubation with monoclonal antibodies (10 mg/ml) in TTBS. Membranes were washed in TTBS and incubated with AP-conjugated sheep F(ab) 2 anti-mouse IgG (Sigma) diluted to 1:20 000 in TTBS or with HRP-conjugated rabbit F(ab) 2 anti-human IgG Antibody-binding Ad for targeted gene delivery P Henning et al (Dako) diluted to 1:800 in TTBS. Membranes were washed in TTBS and TBS, and developed with AP or HRP substrate kit (Bio-Rad Laboratories). As a positive control, a separate membrane was incubated with a laboratory-made mouse monoclonal against fiber knob (mAb H14). The C2 domain has some F(ab) 2 binding property, as evidenced from the binding of Ad5/R7-C2-C2 to the secondary antibody on control membranes. A signal above the background binding of the secondary antibody was then interpreted as positive.
Gene transfer assays
Transduction by the different recombinant Ad5 was studied using GFP as the reporter gene. Infections were performed in 24-well plates for 1 h at 371C in 120 ml Iscove's medium. After infection, cells were washed once in Iscove's medium containing 10% serum and 50 mg/ml gentamicin, and kept in medium with the same supplements overnight. After approximately 15 h, the cells were harvested and washed with PBS. GFP-expressing cells were counted by flow cytometry (FACSsort, Becton Dickinson) as described previously.
12
For blocking experiments of Ad5/WT-fiber and Ad5/R7-C2-C2 on 293 and 293Fc3(1) cells, the virus was incubated for 1 h at 371C with serum from C57BL/6 mice (dilution 1:2) or with mouse IgG (Sigma-Aldrich cat. no. I5381; final concentration 100 mg/ml) in Iscove's medium. For retargeting of Ad5/R7-Zwt-Zwt and Ad5/R7-C2-C2, the virus was preincubated for 1 h at 371C with increasing concentrations of monoclonal antibodies in 120 ml Iscove's medium.
Adenovirus cell-binding assays
Cells were seeded in 24-well culture plates the day before the experiment. On the day of the experiment, the cells in one well were detached and counted to be able to calculate the amount of virus needed to give an MOI of 2.5 PFU/cell. Viruses were incubated with C242 mAb at 5 mg/ml in Iscove's medium in a total volume of 120 ml at 371C for 1 h, after which the virus/mAb mix was transferred to 41C. Cells were washed twice with icecold Iscove's before the addition of virus/mAb. Cells were incubated with the virus/mAb mix for 30 min at 41C. They were detached with nonenzymatic celldissociation solution (Sigma-Aldrich, C5789), washed once in PBS, centrifuged onto microscope slides in a Cytospin2 cytocentrifuge (Thermo Shandon, Pittsburgh, PA, USA) and air-dried overnight. Cell-bound Ad was detected using FITC-conjugated anti-hexon antibody (IMAGEN Adenovirus kit, cat. No. K6100) purified from Evans blue by PD10 column (Amersham Biosciences, cat. no. 17-0851-01). C242 antibody was detected using TRITC-conjugated rabbit F(ab) 2 anti-mouse IgG (Dako, cat. no. R0270). Negative controls, without antibody for CA242 expression, and without antibody, virus or both for virus binding, were performed and showed no staining.
Cell surface expression of a v -integrins, CAR, and PSMA Cells were passaged so as to yield rapidly proliferating cells on the day of staining. Cells were detached with nonenzymatic cell dissociation solution, counted, washed once with PBS, and then incubated with antiintegrin a v , anti-CAR, anti-PSMA or an unspecific isotype control antibody for 30 min at +41C. Cells were washed twice with PBS and then incubated with FITCconjugated rabbit F(ab) 2 anti-mouse IgG for 30 min at 41C. After two PBS washings, the cells were suspended in PBS and the FITC staining was measured by FACS. Mean fluorescence intensities (MFI) for staining with specific anti-integrin a v and anti-CAR were corrected for background isotype control by subtracting the MFI of the isotype control. Expression is given as the percent of expression on 293 cells, which are set to 100%.
